Carolinas Wealth Consulting’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-47
Closed -$1.86K 623
2025
Q1
$1.86K Hold
47
﹤0.01% 819
2024
Q4
$1.92K Hold
47
﹤0.01% 839
2024
Q3
$1.83K Hold
47
﹤0.01% 832
2024
Q2
$2.06K Hold
47
﹤0.01% 793
2024
Q1
$2.24K Hold
47
﹤0.01% 778
2023
Q4
$2.22K Hold
47
﹤0.01% 728
2023
Q3
$1.89K Hold
47
﹤0.01% 754
2023
Q2
$2.73K Hold
47
﹤0.01% 773
2023
Q1
$3.36K Hold
47
﹤0.01% 750
2022
Q4
$3.31K Hold
47
﹤0.01% 747
2022
Q3
$3K Hold
47
﹤0.01% 731
2022
Q2
$3K Hold
47
﹤0.01% 730
2022
Q1
$3K Hold
47
﹤0.01% 768
2021
Q4
$3K Hold
47
﹤0.01% 783
2021
Q3
$3K Hold
47
﹤0.01% 749
2021
Q2
$4K Hold
47
﹤0.01% 735
2021
Q1
$4K Hold
47
﹤0.01% 742
2020
Q4
$4K Hold
47
﹤0.01% 677
2020
Q3
$2K Hold
47
﹤0.01% 724
2020
Q2
$2K Buy
+47
New +$2.23K ﹤0.01% 505

Other funds holding NGVT

Carolinas Wealth Consulting's NGVT Position: Q2 2025 in Review

Carolinas Wealth Consulting sold out of Ingevity (NGVT) in Q2 2025, closing a stake of 47 shares — an estimated $1.86K sold.

Carolinas Wealth Consulting first reported a position in NGVT in Q2 2020 and held it in 20 quarters. The position peaked at $4K in Q2 2021. 269 funds tracked by Wall St. Rank hold NGVT as of Q2 2025.

  • Carolinas Wealth Consulting reported no remaining Ingevity position as of Q2 2025 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 47 Ingevity shares in Q2 2025, an estimated $1.86K.
  • Carolinas Wealth Consulting first reported a position in Ingevity in Q2 2020 and held it in 20 quarters.
  • Carolinas Wealth Consulting's Ingevity position peaked at $4K in Q2 2021.
  • 269 funds tracked by Wall St. Rank held Ingevity as of Q2 2025.

Based on Carolinas Wealth Consulting's 13F filing for Q2 2025.